Purpose: To evaluate the efficacy of an intravitreal dexamethasone (Dex) implant 0.7 mg compared with intravitreal ranibizumab (Ra) for the treatment of radiation maculopathy with macular edema secondary to plaque brachytherapy in choroidal melanoma. Methods: Eight patients were treated with intravitreal Ra, and eight patients received the Dex intravitreal implant. Visual acuity and foveal thickness were evaluated using spectral domain optical coherence tomography. Results: The mean calculated irradiation to the fovea and mean times from brachytherapy to maculopathy development did not differ significantly between groups. In the Ra group, a mean 7.8 ± 3.9 injections were given and the mean follow-up was 33 ± 15 months (range, 7-52 months). ...
Purpose: To compare the efficacy of intravitreal (IV) ranibizumab (IVR) injection with IV dexamethas...
Purpose: To retrospectively study the efficacy of a single 0.7-mg dexamethasone intravitreal implant...
Objective. - To compare the efficacy and safety of intravitreal ranibizumab (RZB) injections and int...
Purpose: To evaluate the efficacy of an intravitreal dexamethasone (Dex) implant 0.7 mg compared wit...
PURPOSE: To evaluate the efficacy and safety of sequential therapy with ranibizumab followed by dexa...
Purpose: To compare the efficacy of intravitreal injection of ranibizumab, dexamethasone implant and...
Purpose: To compare the short-term effects of three monthly intravitreal bevacizumab (IVB) injection...
Francesco Stringa, Federico Marzi, Laura Giannì, Manuela Imparato, Alessa...
Purpose: To compare the efficacy and safety of three intravitreal bevacizumab upload injections foll...
PURPOSE: To investigate the efficacy of the intravitreal dexamethasone implant as the treatment for ...
Purpose: To report the effective treatment of radiation macular edema following ruthenium-106 plaque...
To evaluate the efficacy and duration of activity of a single intravitreal dexamethasone implant in ...
Purpose: To compare the short-term effects of three monthly intravitreal bevacizumab (IVB) injection...
1. Objective: The study compares the effectiveness of an intravitreal slow-release dexamethasone imp...
Purpose: To compare the clinical outcome of intravitreal dexamethasone implant versus oral acetazola...
Purpose: To compare the efficacy of intravitreal (IV) ranibizumab (IVR) injection with IV dexamethas...
Purpose: To retrospectively study the efficacy of a single 0.7-mg dexamethasone intravitreal implant...
Objective. - To compare the efficacy and safety of intravitreal ranibizumab (RZB) injections and int...
Purpose: To evaluate the efficacy of an intravitreal dexamethasone (Dex) implant 0.7 mg compared wit...
PURPOSE: To evaluate the efficacy and safety of sequential therapy with ranibizumab followed by dexa...
Purpose: To compare the efficacy of intravitreal injection of ranibizumab, dexamethasone implant and...
Purpose: To compare the short-term effects of three monthly intravitreal bevacizumab (IVB) injection...
Francesco Stringa, Federico Marzi, Laura Giannì, Manuela Imparato, Alessa...
Purpose: To compare the efficacy and safety of three intravitreal bevacizumab upload injections foll...
PURPOSE: To investigate the efficacy of the intravitreal dexamethasone implant as the treatment for ...
Purpose: To report the effective treatment of radiation macular edema following ruthenium-106 plaque...
To evaluate the efficacy and duration of activity of a single intravitreal dexamethasone implant in ...
Purpose: To compare the short-term effects of three monthly intravitreal bevacizumab (IVB) injection...
1. Objective: The study compares the effectiveness of an intravitreal slow-release dexamethasone imp...
Purpose: To compare the clinical outcome of intravitreal dexamethasone implant versus oral acetazola...
Purpose: To compare the efficacy of intravitreal (IV) ranibizumab (IVR) injection with IV dexamethas...
Purpose: To retrospectively study the efficacy of a single 0.7-mg dexamethasone intravitreal implant...
Objective. - To compare the efficacy and safety of intravitreal ranibizumab (RZB) injections and int...